Recipharm has entered into a long term supply agreement with Tillotts Pharma AG for the technology transfer and commercial manufacture of Entocort and Asacol. The agreement will also involve the commercial scale development of Tillotts’ ongoing development program for TP05. All products are part of Tillotts’ gastroenterology therapies.   Recipharm will provide pellet coating technology for controlled release from its facility in Pessac, France, tablet and capsule manufacturing including final ...